VS

Vipul Sumanbhai Shah

Active Director Designated Partner DIN 08870979
DIN 08870979 First appointment Sep 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Vipul Sumanbhai Shah

Data last updated:

Vipul Sumanbhai Shah is a Designated Partner at Sibyl Pharma Llp (since 2020). The company operates in Pharma.

DIN 08870979
Primary Designation Designated Partner
Industry Pharma
First Appointment 09 Sep 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sibyl Pharma Llp AAT-7510
Designated Partner09 Sep 20202020Active

Board colleagues of Vipul Sumanbhai Shah

NameDINCompanyDesignation
Harsh Nitinbhai Shah06827523Sibyl Pharma LlpDesignated Partner
Nitinchandra Savailal Shah00330170Sibyl Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Sibyl Pharma Llp
Premium access

Shareholding and investment profile for Vipul Sumanbhai Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vipul Sumanbhai Shah

Vipul Sumanbhai Shah currently holds 1 directorship: Sibyl Pharma Llp (Designated Partner, since 09 Sep 2020).

Vipul Sumanbhai Shah was first appointed on 09 Sep 2020 as Designated Partner at Sibyl Pharma Llp.

The current boards of Vipul Sumanbhai Shah's companies include Harsh Nitinbhai Shah (Sibyl Pharma Llp), Nitinchandra Savailal Shah (Sibyl Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available